| Make the following changes when using
rapid-acting analogues compared to unmodified human insulin : |
 |

 |
monitor the effect of a short-acting analogue post-prandially ( at 1-2 h
), and always less than 4 h after injection |
|

 |
expect to use lower pre-meal insulin doses than with human insulin |
|

 |
use combined NPH + analogue injection before meals, if the between-meal
interval is to be greater than 5 h |
|

 |
use a higher late-evening NPH dose ( unless the aim is specifically to
deal with a problem of night-time hypoglycaemia ) |
|

 |
use late-evening NPH no longer than 4 h after the evening analogue
injection |